Featured Journal Publications
Project Data Sphere’s success is ultimately measured by the practice-changing scientific insights discovered by the research community. We are proud to highlight some of the peer-reviewed publications based on data from the PDS platform that have sparked changes in clinical or research practices.
Author(s) | Date | Article Title | Journal |
---|---|---|---|
Qiyu Wang, Ian A. Strohbehn, Sophia Zhao, Harish Seethapathy, Samuel D. Strohbehn, Paul Hanna, Meghan Lee, Riley Fadden, Ryan J. Sullivan, Genevieve M. Boland, Kerry L. Reynolds, Meghan E. Sise |
August 2022 | Effect of Cancer Stage on Adverse Kidney Outcomes in Patients Receiving Immune Checkpoint Inhibitors for Melanoma | ScienceDirect |
Sophia Z. Shalhout, Kevin S. Emerick, Howard E. Kaufman, David M. Miller |
June 2022 | A retrospective study of ipilimumab plus nivolumab in anti–PD-L1/PD-1-refractory merkel cell carcinoma | Journal of Clinical Oncology |
Steffen Ventz, Sean Khozin, Bill Louv, Jacob Sands, Patrick Y. Wen, Leah Comment, Brian M. Alexander, Lorenzo Trippa |
March 2022 | The Design and Evaluation of Hybrid Controlled Trials that Leverage External Data and Randomization | Research Square |
Yu, Peter MD, ET AL |
February 2022 | Artificial Intelligence Comes of Age in the Fight Against Cancer | Oncology Times |
Sophia Z Shalhout, Farees Saqlain, Kayla Wright, Oladayo Akinyemi, David M Miller |
January 2022 | Generalizable EHR-R-REDCap pipeline for a national multi-institutional rare tumor patient registry | Jamia Open |
Leeann B Burton, Mahsa Eskian, Amanda C Guidon, Kerry L Reynolds |
November 2021 | A review of neurotoxicities associated with immunotherapy and a framework for evaluation | Neuro-Oncology Advances |
Rifaquat Rahman, Steffen Ventz, Jon McDunn, Bill Louv, Irmarie Reyes-Rivera, Mei-Yin C Polley, Fahar Merchant, Lauren E Abrey, Joshua E Allen, Laura K Aguilar, Estuardo Aguilar-Cordova, David Arons, Kirk Tanner, Stephen Bagley, Mustafa Khasraw, Prof Timothy Cloughesy, Prof Patrick Y Wen, Brian M Alexander, Lorenzo Trippa |
September 2021 | Leveraging external data in the design and analysis of clinical trials in neuro-oncology | Lancet Oncology |
Amanda C Guidon, Leeann B Burton, Bart K Chwalisz, James Hillis, Teilo H Schaller, Anthony A Amato, Allison Betof Warner, Priscilla K Brastianos, Tracey A Cho, Stacey L Clardy, Justine V Cohen, Jorg Dietrich, Michael Dougan, Christopher T Doughty, Divyanshu Dubey, Jeffrey M Gelfand, Jeffrey T Guptill, Douglas B Johnson, Vern C Juel, Robert Kadish, Noah Kolb, Nicole R LeBoeuf, Jenny Linnoila, Andrew L Mammen, Maria Martinez-Lage, Meghan J Mooradian, Jarushka Naidoo, Tomas G Neilan, David A Reardon, Krista M Rubin, Bianca D Santomasso, Ryan J Sullivan, Nancy Wang, Karin Woodman, Leyre Zubiri, William C Louv, Kerry L Reynolds |
July 2021 | Consensus disease definitions for neurologic immune-related adverse events of immune checkpoint inhibitors | Journal for ImmunoTherapy of Cancer |
Aakanksha Khandelwal, Mace Rothenberg, Sean Khozin, Amanda C Guidon, Michael Dougan, Leyre Zubiri, Laura Petrillo, Meghan E Sise, Alexandra-Chloe Villani, Douglas B Johnson, Osama Rahma and Elad Sharon |
July 2021 | Immune-related adverse events associated with immune checkpoint inhibitors: a call to action for collecting and sharing clinical trial and real-world data | Journal for ImmunoTherapy of Cancer |
Geoffrey Fell, Robert A Redd, Alyssa M Vanderbeek, Rifaquat Rahman, Bill Louv, Jon McDunn, Andrea Arfè, Brian M Alexander, Steffen Ventz, Lorenzo Trippa |
June 2021 | KMDATA: a curated database of reconstructed individual patient-level data from 153 oncology clinical trials | Database |
Shalhout, Sophia Z.; Kaufman, Howard L.; Sullivan, Ryan J.; Lawrence, Donald; Miller, David M. |
June 2021 | Immune Checkpoint Inhibition in Marjolin Ulcer: A Case Series | Journal of Immunotherapy |
Steffen Ventz, PhD, Leah Comment, PhD, Bill Louv, PhD, Rifaquat Rahman, MD, Patrick Y Wen, MD, Brian M Alexander, MD, Lorenzo Trippa, PhD |
June 2021 | The Use of External Control Data for Predictions and Futility Interim Analyses in Clinical Trials | Neuro-Oncology |
Amanda C Guidon, Leeann B Burton, Bart K Chwalisz, James M Hillis, Teilo Schaller, Kerry Lynn Reynolds, Neuro irAE Disease Definition Panel |
May 2021 | Consensus disease definitions for the spectrum of neurologic immune related adverse events | Journal of Clinical Oncology |
Sophia Z.Shalhout, PhD; Jong ChulPark, MD; Kevin S.Emerick,MD; Ryan J.Sullivan, MD; Howard L.Kaufman, MD; David M.MillerMD, PhD |
January 2021 | Real-world assessment of response to anti-PD-1 therapy in advanced cutaneous squamous cell carcinoma | Journal of the American Academy of Dermatology |